http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010215763-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79f07aaaebb73f9cb4c7a9c7cf8af402 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-24 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-24 |
| filingDate | 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b53f7b1a677ec63b30d842f33d8b18a3 |
| publicationDate | 2010-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2010215763-A1 |
| titleOfInvention | Method of using the body's alternative cellular energy pigments (ACE-pigments) in the therapy of diseases |
| abstract | Alternative cellular energy pigments (ACE-pigments) are over-produced in response to various types of viral infections and to other pathological conditions. ACE pigments accumulate at the sites of disease and also in other regions of the body, including the oral cavity. ACE pigments are considered to play a significant role in the body's healing response to both local and system diseases. They appear to exist in a relatively inactive form in which they can fluorescence under ultraviolet (UV) light illumination, especially if stained with a suitable dye, such as neutral red. The present invention describes a method of using ACE pigments collected from the saliva (spittle) of patients for the purpose of activating the ACE pathway in a child with autism and in an adult with an active skin lesion caused by herpes simplex virus. The saliva containing the collected ACE pigments is placed onto a suitable material, such as a paper towel, stained with neutral red dye and induced to fluoresce using UV illumination. The fluorescing mixture is placed over various areas of the body of a child with autism and/or directly placed over the herpes simplex virus induced skin lesions, and the UV illumination continued. This process will partially activate the ACE pathway in the patient with resulting clinical benefit. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10039777-B2 |
| priorityDate | 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.